Find more information on the Altmetric Attention Score and how the score is calculated. Spiral phase contrast imaging and bright-field imaging are two widely used modes in microscopy, providing ...

Abstract: In this manuscript, low-cost and efficient protection scheme for three phase induction motors is designed against the most commonly occurring abnormal conditions – over current, over voltage ...

Abstract: In this article, a novel predictive torque and stator flux control (PTSF) method is proposed for N-segment three-phase permanent magnet synchronous motor (N*3-phase PMSM), which can ...

Mumbai’s underground Metro Line-3 took a big step forward with the opening of its Phase 2A on May 9, connecting Bandra-Kurla Complex (BKC) to Acharya Atre Chowk in Worli. The new stretch was ...

ISLAMABAD: The government’s second-phase auction for three dysfunctional or closed thermal power plants received a lukewarm response, with only one party submitting a bid — for the Jamshoro ...

Residents of J.P. Nagar have raised serious concerns about the proposed double-decker flyover under Namma Metro Phase 3, warning that its alignment could worsen traffic congestion near the already ...

Dive into Sprunki MSI Canon Phase 3, where new characters and immersive soundscapes deepen the narrative. Experience a thrilling evolution of dark themes. Sprunki MSI Phase 3 represents a thrilling ...

rNIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK sUniversity Hospitals Sussex NHS Foundation Trust, ...

BioMarin has followed through on its shift to external innovation, inking a deal to buy Inozyme for $270 million to add a phase 3 enzyme replacement therapy to its pipeline. California-based ...

Phase II Study (NO LIMIT, WJOG13320G ... One hundred seventy patients (142 events) were needed to detect an increase of 3 months in PFS with 80% power (log-rank test, 5% two-sided α). One hundred ...

But with promising early results from a phase 3 study in certain patients, the checkpoint inhibitor may have found its place. At a pre-specified interim analysis of Merck’s phase 3 Keynote-B96 ...

In 2024, Merck announced the initiation of the Phase 2/3 REJOICE-Ovarian01 trial evaluating raludotatug deruxtecan (R-DXd), an investigational potential first-in-class CDH6 directed DXd antibody ...